Principal Healthcare Innovators ETF (BTEC)

Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?

As rising rates are in the cards, value stocks are likely to take a center stage in the near term.

How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

If the ongoing pandemic has taught anything, it's the need for healthcare innovation. That's exactly what the Principal Healthcare Innovators ETF (BTEC) is all about.

In an effort to combat the coronavirus outbreak and accelerate the distribution process of extra doses in the United States, the FDA has approved the vaccine booster shots.

The U.S. government's plans to make COVID-19 vaccine booster shots available from next month will likely increase the profits of vaccine makers.

Two ESG-related ETFs launched this week, and both are heavy on the 'E.'

The biotech sector seems like a lucrative investment space as the delta variant of coronavirus continues to spread.

These four ETF areas were winners last week.

Investors may want to tap the bullishness in the sector with the best biotech ETFs of last week.

Broadly speaking, the healthcare sector is generally viewed as defensive, but there growing pockets of disruption and innovation in the space, including health technology equities. For investors looking for healthcare with a growth feel, the Principal Healthcare Innovators Index ETF (BTEC) is one exchange traded fund to consider.

Let's take a look at some top coronavirus vaccine stories of May and the possible impact they can have on biotech ETFs.

The Biden administration recently informed about supporting the waiver of intellectual property protections for COVID-19 vaccines that has been proposed by South Africa and India.

Let's take a look at some top coronavirus vaccine stories of April and the possible impact they can have on biotech ETFs.

In the upcoming webcast, Investing for tomorrow, today: Exploring the future of health care, Steve Jones, Client Portfolio Manager, Principal Global Systematic Solutions; Jeffrey Schwarte, Portfolio Manager and Head of Systematic Solutions, Principal Global Systematic Solutions; and Matthew Cohen, Head of ETF Specialist Team, Principal Global Investors, will highlight the healthcare and technology investment themes [...] The post Investing for Tomorrow, Today: Exploring the Future of Health Care appeared first on ETF Trends.

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of this year, as operations that were disrupted return to normal.